Immix Biopharma: Funding, Investors & Team (Oct 2026)
Immix Biopharma is a biotech company that develops treatments for cancer and other inflammation-driven diseases.
Immix Biopharma has raised $265M across 3 funding rounds on record, the most recent an undisclosed round of $150M announced in May 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Immix Biopharma Company Profile and Key Stats
Latest funding round on record: May 2026.
Immix Biopharma Funding Rounds
Immix Biopharma raised $15.0M in an undisclosed round announced in Feb 2024.
1.8 years later, an undisclosed round of $100M was announced in Dec 2025.
5 months later, an undisclosed round of $150M was announced in May 2026.
Immix Biopharma Founders and Leadership Team
Contact details for the Immix Biopharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Immix Biopharma Funding Compared to Other Biotechnology Startups
Immix Biopharma's latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Immix Biopharma in Biotechnology and Los Angeles
Companies Similar to Immix Biopharma
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Immix Biopharma Funding FAQs
What does Immix Biopharma do?
Immix Biopharma is a biotech company that develops treatments for cancer and other inflammation-driven diseases.
How much funding has Immix Biopharma raised?
Immix Biopharma has raised $265M across 3 rounds on record. The most recent is an undisclosed round of $150M announced in May 2026.
When did Immix Biopharma last raise funding?
Immix Biopharma's most recent funding round on record is an undisclosed round of $150M, announced in May 2026.
Who founded Immix Biopharma?
FundedIQ lists Ilya Rachman (Founder) at Immix Biopharma.
Where is Immix Biopharma headquartered?
Immix Biopharma is based in Los Angeles, California, United States.
How many employees does Immix Biopharma have?
Immix Biopharma is in the 11-50 employee band.
How does Immix Biopharma's funding compare to other Biotechnology startups?
Immix Biopharma's latest round of $150M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Immix Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Immix Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.